Concepedia

Ekram Gad

EG

Statistics

Publications

28

Citations

1.4K

H-Index

21

Active since

2006

Affiliations

University of Washington(Current)

Institute of Translational Health Sciences

Korea University

Bastyr University

Infectious Disease Research Institute

Ekram Gad is an author at University of Washington specializing in immunology, oncology, and cancer immunotherapy.

Publications per year

2006–2024

28

Publications

28

Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells

Hailing Lu, Yi Yang, Ekram Gad et al. · Clinical Cancer Research · 2010 · 144 citations · Full text

, , +16

Immunoediting of Cancers May Lead to Epithelial to Mesenchymal Transition

Keith L. Knutson, Hailing Lu, Brad Stone et al. · The Journal of Immunology · 2006 · 129 citations

, , +17

IL-2 Immunotoxin Therapy Modulates Tumor-Associated Regulatory T Cells and Leads to Lasting Immune-Mediated Rejection of Breast Cancers in <i>neu</i> -Transgenic Mice

Keith L. Knutson, Yushe Dang, Hailing Lu et al. · The Journal of Immunology · 2006 · 126 citations · Full text

, , +17

TLR2 Agonist PSK Activates Human NK Cells and Enhances the Antitumor Effect of HER2-Targeted Monoclonal Antibody Therapy

Hailing Lu, Yi Yang, Ekram Gad et al. · Clinical Cancer Research · 2011 · 90 citations · Full text

, , +17

The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity

Marshall D. Behrens, Wolfgang Wagner, Christopher J. Krco et al. · Blood · 2007 · 84 citations · Full text

, , +15

1–5 of 28